PHIOPhio Pharmaceuticals Corp.vs its industry peers
A metric-by-metric comparison of Phio Pharmaceuticals Corp. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PHIO본 종목 | $10M#7 | — | 0.8x#2 | — | -100.0%#7 | -21.7%#9 | — | -69.0%#2 | — | — | — | — |
| BIVI | $11M#1 | — | 1.0x#3 | — | — | -25.8%#10 | — | -214.9%#6 | -1671.2%#2 | — | — | — |
| LIPO | $11M#2 | — | 7.1x#9 | 19.8x#6 | 19.3%#2 | -8.6%#8 | -947.2%#5 | -337.2%#9 | — | — | — | — |
| DARE | $11M#3 | — | — | 10.3x#5 | 10429.4%#1 | -230.9%#14 | -1315.5%#6 | — | — | — | — | — |
| TVRD | $11M#4 | — | 1.3x#5 | 1.5x#2 | -66.0%#5 | 38.1%#3 | -374.8%#4 | -217.3%#7 | — | — | — | — |
| BPTH | $11M#5 | — | — | — | -100.0%#7 | 38.5%#2 | — | — | — | — | -66.5%#2 | — |
| ARTL | $10M#6 | — | 2.1x#8 | — | — | -31.1%#12 | — | -257.7%#8 | — | — | — | — |
| LSTA | $9M#9 | — | 1.1x#4 | 53.3x#7 | -83.0%#6 | 15.0%#6 | -10711.2%#8 | -206.2%#5 | — | 3#1 | — | — |
| BFRG | $9M#8 | — | 1.3x#7 | 78.3x#8 | — | 7.1%#7 | -5652.4%#7 | -93.0%#3 | -5287.3%#3 | — | — | — |
| PTN | $9M#10 | — | 1.3x#6 | 0.7x#1 | — | 51.6%#1 | -65.7%#1 | -125.3%#4 | — | — | — | — |
| ENSC | $9M#11 | — | — | 1.7x#4 | -2.8%#4 | -27.4%#11 | -202.1%#3 | — | — | — | — | — |
| ACTU | $9M#13 | — | 8.7x#11 | — | — | 18.5%#4 | — | -2247.2%#11 | — | — | -94.6%#3 | — |
| LTRN | $9M#12 | — | — | — | — | 17.6%#5 | — | — | — | — | — | — |
| INM | $8M#14 | — | 7.7x#10 | 1.7x#3 | 7.5%#3 | -53.9%#13 | -160.8%#2 | -1168.4%#10 | — | — | — | — |
| KPRX | $8M#15 | — | 0.5x#1 | — | -100.0%#7 | -401.4%#15 | — | -0.1%#1 | -127.6%#1 | — | -20.4%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice